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Abstract
L-glutamate, an excitatory neurotransmitter, binds to both ionotropic and metabotropic glutamate
receptors. In certain parts of the brain the BBB contains two normally impermeable barriers: 1)
cerebral endothelial barrier and 2) cerebral epithelial barrier. Human cerebral endothelial cells
express NMDA receptors; however, to date, human cerebral epithelial cells (neuroepithelial cells)
have not been shown to express NMDA receptor message or protein. In this study, human
hypothalamic sections were examined for NMDA receptors (NMDAR) expression via
immunohistochemistry and murine neuroepithelial cell line (V1) were examined for NMDAR via
RT-PCR and Western analysis. We found that human cerebral epithelium express protein and
cultured mouse neuroepithelial cells express both mRNA and protein for the NMDA receptor.
These findings may have important consequences for neuroepithelial responses during
excitotoxicity and in disease.
Background
Glutamate receptor stimulation is an important physio-
logical event, which helps regulate learning and memory
development. [1]. In the mammalian nervous system, L-
glutamate binds to several classes of 'glutamatergic' recep-
tors, which are classified into two major groups, metabo-
tropic and ionotropic. Within the ionotropic family of
glutamate receptors there are three subtypes (based upon
their binding and activation by AMPA, kainic acid, and
NMDA): 1) α-amino-3-hydroxy-5-methyl-4-isoxazole
propionate (AMPA), 2) kainic acid (KA) receptors, and 3)
N-methyl-D-aspartate (NMDA) receptors [2].
Glutamate is present at concentrations ranging from 18–
25 µM in plasma [3], 0.3 µM in the cerebral spinal fluid
(CSF), and as high as 3 mM within the parenchymal cell
stores [4-6]. However, under ischemic or traumatic condi-
tions the glutamate concentration levels in the brain inter-
stitial space can increase 55-fold [7] to levels that are toxic
to neurons.
During stroke and trauma it has been suggested that
majority of glutamate released (although not the only
pathway) is due to neuronal injury within the cerebrum,
which is provoked by cerebral oxygen and glucose depri-
vation, resulting in the excessive release of stored synaptic
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glutamate. Glutamate synaptic release is due to the loss of
ATP stores and dissipation of membrane ion gradients
leads to K+ efflux, and membrane depolarization. Eventu-
ally anoxia triggers a massive depolarization and opening
of voltage-dependent Na+ channels. As a result, glutamate
is released by synaptic exocytosis and trapped in the inter-
stitium, due to the reversal of the glutamate transporters
flooding the synaptic space with glutamate. This response
in turn leads to the massive over-stimulation of NMDA
receptors, referred to as 'glutamate excitotoxicity' [8-11]. In
addition to neuronal excitotoxicity, increased extracellular
glutamate may also contribute to 'vasogenic edema' (char-
acterized by an increase in microvascular solute permea-
bility) [12-18].
In the hypothalamus, neuroepithelial or ependymal cells
create a second brain solute "barrier" [19], which sepa-
rates the brain parenchyma from the CSF. If the neuroep-
ithelium maintains the same tight junctional
characteristics as non-cerebral epithelial cells, then they
will create a significantly tighter barrier than those formed
by most of the endothelium, including that of the blood
brain barrier (BBB) [20-22]. During inflammation extra-
cellular pathogens may penetrate the cerebrum through
both the endothelial and epithelial barriers, demonstrat-
ing that infection of the cerebrum can occur from the
direction of either the blood or the CSF [23]. These data
suggest that the CSF barrier, like that of the endothelium,
might also be compromised in disease.
In this study we demonstrated NMDA receptor expression
on cerebral epithelia within human cerebral tissue and
murine neuroepithelial cells. The presence of the NMDA
receptor 1 (NMDAR1) on human neuroepithelium is
demonstrated via immunohistochemistry and mRNA and
protein expression for the NMDA receptors in cultured
murine neuroepithelial cells suggest that their function is
conserved among species.
Results
V1 (neuroepithelial cells) and Normal Human Brain Tissue 
RT-PCR for NMDAR1
Human cerebral endothelial cells (IHEC), which had pre-
viously been shown to express mRNA for NMDAR1 [24],
were used as a positive control for determining if the V1
cells contained message for the NMDAR1. With the use of
primer sets designed for NMDAR1 we were able to demon-
strate that the V1 cells contained message for NMDAR1
(Figure 1). Figure 1 shows a ~680 bp band that was specif-
ically amplified.
V1 and Normal Rat Cerebral Tissue Western Analysis for 
NMDAR 1 and 2A/B
Rat cerebral lysate (positive control supplied by Chemi-
con) and Neuroepithelial cell protein from V1 cells were
separated on SDS-PAGE gels and western blots (using
antibodies specific for NMDAR1 and NMDAR2A/B) showed
a ~116 and ~160 KD bands, the anticipated sizes for
NMDA receptor subunit 1 and 2A/B, respectively (Figure
2). This matches the two reported size bands by Sharp et
al. 2002 [24].
Human Hypothalamic Immunohistochemistry for the 
NMDAR1
Immunohistochemical staining of a human adult hypoth-
alamic paraffin slide revealed that the cerebral epithelial
cells (Choroid Plexus epithelial cells, Figure 3A, and
ependymal cells, Figure 3B) express NMDAR1, which
appeared to be concentrated on the apical (ventricular/
CSF) side. We found that staining appeared to be
RT-PCR (30 cycles) was performed with primers specific for  mouse and human NMDAR1, which revealed that both V1  (mouse neuroepithelial cells) and IHEC (Human cerebral  endothelial cells – positive control) express mRNA for  NMDAR1 Figure 1
RT-PCR (30 cycles) was performed with primers specific for 
mouse and human NMDAR1, which revealed that both V1 
(mouse neuroepithelial cells) and IHEC (Human cerebral 
endothelial cells – positive control) express mRNA for 
NMDAR1. The bands were determined to be ~680 bps and 
~670 bps and match the anticipated size of mouse and human 
NMDAR1 (respectively).
RT-PCR for NMDAR1
V1 IHEC Base
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segregated to the apical side (CSF compartment) of the
nucleus. Other sections were used to examine control
staining and confirmed the specificity of the antibody and
procedure.
Discussion
Extracellular pathogens can penetrate the cerebrum
through either the epithelial and endothelial barrier dur-
ing events such as stroke and cerebral inflammation [23].
Many studies have considered possible mechanisms for
the endothelial barrier disruption during trauma/excito-
toxicity. We have recently reported that when the human
cerebral endothelium was stimulated with either gluta-
mate or NMDA there was a NMDA-type glutamate recep-
tor dependent cerebral endothelial barrier dysfunction
[24]); however, the mechanisms through which the neu-
roepithelial barrier might be disrupted have not been
investigated. If neuroepithelial cells express NMDAR1,
then during excitotoxic events (like stroke), when the CSF
glutamate concentration increases, there could be a mas-
sive efflux of Ca2+ into the neuroepithelial cells. Altered
intracellular Ca2+ might then lead to an increase in solute
permeability, as has been proposed within endothelial
systems [25].
Neuroepithelial cells also express highly efficient gluta-
mate transporters, which are at least partially responsible
for maintaining the low concentrations of glutamate in
the CSF by actively moving glutamate from the CSF to the
parenchyma [26,27]. In fact these transporters create a 7-
fold higher concentration of glutamate in the parenchyma
(compared to the CSF) in under 5 min (with steady state
reached within 15 min, as high as 30-fold) [26]. These
cells also metabolize glutamine to glutamate in addition
to transporting glutamate across the epithelia [26,27].
Therefore, NMDA receptors present on the "apical" sur-
face might regulate the activity of these transporters to
control glutamate homeostasis between CSF and
parenchyma.
Immunohistochemical staining of the human ependymal
sections demonstrated that the nuclei separated the neu-
roepithelial cells into apical (facing the CSF) and
V1 cell protein and rat brain lysate positive control (supplied  by Chemicon) were separated on 7.5% denaturing SDS- PAGE gels Figure 2
V1 cell protein and rat brain lysate positive control (supplied 
by Chemicon) were separated on 7.5% denaturing SDS-
PAGE gels. Comparison of the control and V1 cell band 
(~116 kD) present after western analysis demonstrated that 
V1 cells do express protein for NMDA subunits 1 and 2A/B.
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Human hypothalamus sections (A = choriod plexus and B =  ependymal cell barrier) were stained for NMDAR1 and dem- onstrated a uniform and consistent pattern of staining that is  associated with the apical side (CSF) with very little staining  basally Figure 3
Human hypothalamus sections (A = choriod plexus and B = 
ependymal cell barrier) were stained for NMDAR1 and dem-
onstrated a uniform and consistent pattern of staining that is 
associated with the apical side (CSF) with very little staining 
basally. The magnified section of Figure 3, further illustrates 
this specific orientation (also pointed out by the arrows). 
The blood vessels are labeled 'BV' and nuclei are labeled "N".
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basolateral (facing the parenchyma/vascular) surfaces. We
saw a clear and distinct spatial association of NMDAR1
staining with the apical side with a paucity of basal stain-
ing, suggesting that the neuroepithelial cells could possi-
bly function as detectors of CSF glutamate concentration
levels, which are normally 0.3 µM but have been shown
to increase 55-fold under ischemic/traumatic conditions
[7]. These data support possible roles for NMDA-receptors
in regulating glutamate transporters, as previously
described.
Conclusion
Therefore, the results of the present study, which evalu-
ated neuroepithelial cell expression of NMDA-type gluta-
mate receptors via RT-PCR, Western analysis, and
immunohistochemistry supports the position that cere-
bral epithelia express the NMDA-receptor at the mRNA
(Figure 1), protein (Figure 2), and tissue levels (Figure 3).
As stated above, two potential roles for neuroepithelial
NMDA receptors may include: 1) control of CSF homeos-
tasis by controlling the activity of the glutamate transport-
ers and 2) disruption of the neuroepithelial barrier during
disease/excitotoxic processes; however, we can only cur-
rently speculate on the function of these receptors. Future
studies will examine each of these possible functions of
the neuroepithelial NMDA receptor.
Methods
Reagents for Tissue Culture
M-199, Insulin, Transferrin, Selenium, Heparin, and
HEPES were purchased from Sigma (St. Louis, MO).
Cell culture
A mouse neuroepithelial cell line (termed "V1") was sup-
plied by Dr. Harvey Ozer (University of Medicine and
Dentistry of New Jersey, Newark). V1 cells were main-
tained in M-199 (with 10% FCS, 1% antibiotic/antimy-
cotic, 5 µg/ml insulin, 5 µg/ml transferrin, 5 ng/ml
Selenium, and 600 USP units/l heparin) and grown to
100% confluency on T-75 flask. The neuroepithelial cul-
tures were used at 1 week in culture (approximately 3 days
after culture confluency was established).
Western Analysis
Protein samples (25 ug each) were separated on 7.5%
SDS-PAGE gels, electro-transferred to nitrocellulose mem-
branes and blocked overnight in 5% milk in PBS. Mem-
branes were then incubated for 24 hours with anti-human
NMDAR1  and an anti-human NMDAR2A/B  (Chemicon;
Temecula, CA) polyclonal antibody at 1:250 dilution in
0.1% milk in PBS. The membranes were then washed 3 ×
5' (each wash) and incubated overnight at 4°C in goat
anti-mouse alkaline-phosphatase secondary antibody
(Sigma; St. Louis, MO) at a 1:1000 dilution in 0.1% milk
in PBS. The membranes were then reacted with NBT/BCIP
chromogen to visualize the proteins.
RT-PCR
Message for NMDAR1 was determined in both V1 cells
and human brain tissue samples from total RNA (Qiagen
kit number 52304; Qiagen; Seattle, WA). 1 ug of DNAse
treated RNA was converted to cDNA using reverse tran-
scriptase (Promega; Madison, WI) and amplified using
the following primers (from ascension number
BC039157; sense primer for base pairs 1192–1209 and
antisense primer for base pairs 1854-1838): sense primer,
5'-GATGTCTTCCAAGTATGC-3' and antisense primer, 5'-
ATCTCCTTCTTGACCAG-3'. The PCR mixture was ampli-
fied for 30 cycles using a three step protocol: denaturation
at 94°C (1 min), annealing at 50°C for 1 min, and elon-
gation at 72°C for 1 min. The corresponding 670 – 680 bp
(NMDAR1) product was separated in a 1.5% agarose gel
stained with ethidium bromide and viewed and analyzed
using Alpha Innotech gel documentation system (San
Leandro, CA). RNA extracts from human cerebral
endothelial cells (IHEC) were used as the positive control
for all experiments [24]. Negative controls were per-
formed in which the reverse transcriptase enzyme was
omitted and replaced with RNAse free water.
Immunohistochemistry
Paraffin slides were deparaffinized with 2 changes of
xylene (Sigma; St. Louis, MO) for 10 min each. The slides
were transferred to 100% alcohol for 2 changes for 2 min
each. They were incubated for 10 min in 3% H2O2 in
methanol to block endogenous peroxidase activity. The
slides were rinsed 1× in PBS and excess PBS removed.
Slides were blocked with 5% normal serum for 1 hour and
then the anti-human NMDAR1  (Chemicon; Temecula,
CA) polyclonal antibody at a 1:250 dilution in 0.1% milk
(in PBS) was added and allowed to incubate at 4°C over-
night. The next day the slides were rinsed 3× for 2 min
each in PBS. HRP (Sigma; St. Louis, MO) at a 1:1000 dilu-
tions in 0.1% milk was applied to the slides and incubated
for 30 min at room temperature. The slides were washed
3 times in PBS and diaminobenzidine (DAB) solution
(Pharmingen; San Diego, CA) was applied and allowed to
incubate for 5 min. The DAB was drained and the slides
were placed in water for 3 min. Slides were counter-
stained in hematoxylin (Pharmigen; San Diego, CA). The
slides were then dehydrated with the use of 100% alcohol
and then mounting medium and coverslips were applied.
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